锌—α2—糖蛋白在高尿酸血症模型小鼠肾脏中表达的变化(4)
[7] 齊 卡，冯 哲，洪 权，等.尿酸通过诱导线粒体钙稳态失衡介导内皮细胞炎症反应[J].山东医药，2010，50(20)：15-18.
[8] 徐 玮，陈卫东.高尿酸血症对肾损伤的机制研究进展[J].安徽医 学，2017，38(5)：665-667.
[9] 刘李玟韬，杨 洁，陈秉朴.高尿酸血症动物模型研究述评[J].湖南中医药大学学报，2017，37(12)：1431-1436.
[10] RUSSELL S T， TISDALE M J. Mechanism of attenuation of skeletal muscle atrophy by zinc-alpha2-glycoprotein[J]. Endocrinology，2010，151(10)： 4696-4704.
[11] BURGI W， SCHMID K. Preparation and properties of Zn-alph a 2-glycoprotein of normal human plasma[J]. J Biol Chem，1961，236：1066-1074.
[12] SANCHEZ L M， CHIRINO A J， BJORKMAN P. Crystal structure of human ZAG， a fat-dep letting factor related to MHC molecu les[J]. Science， 1999， 283(5409)：1914-1919.
[13] BING C， BAOY， JENKINS J， et al. Zinc-alpha2-glycoprotein， a lipid mobil-izing factor， is expressed in adipocytes and isup-regulated in mice with can-cer cachexia. Proc Natl Acad[J]. SciU SA， 2004， 101(8)：2500-2505.
[14] DUNSTAN D W， ZIMMET P Z， WELBORN T A， et al. The rising prevalence of diabetes and impaired glucose tolerance： The Australian Diabetes， Obesity and Lifestyle Study[J]. Diabetes Care， 2002，25(5)：829-834.
[15] MRACEKT， DING Q， TZANAVARI T， et al. Theadipokine zinc-α2-glycoprotein is downregulated with fat mass expansion in obesity[J]. Clin Endocrinol(Oxf)， 2010，72(3)：334-341.
[16] SELVA D M， LECUBE A， HERNANDEZ C， et al. Lower zinc-{alpha}2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance[J]. J Clin Endocrinol Meta， 2009，94(11)：4499-4507.
[17] MRACEKT， GAO D， TZANAVARI T， et al. Downregulation of zinc-α2-glycoprotein in adipose tissue and liver of obese ob/ob mice and by tumour necrosis factor-αin adipocytes[J]. J Endocrinol，2010，204(2)：165-172.
[18] GOHDA T， MAKITA Y， SHIKE T， et al. Identification of epistatic interaction Involved in obesity using the KK/Ta mouse as a Type2 diabetesmodel： is Zn-alpha2 glycoprotein-1acandidate gene for obesity？[J]. Diabetes， 2003，52(8)：2175-2181., 百拇医药(刘李玟韬 杨洁 陈秉朴)
[8] 徐 玮，陈卫东.高尿酸血症对肾损伤的机制研究进展[J].安徽医 学，2017，38(5)：665-667.
[9] 刘李玟韬，杨 洁，陈秉朴.高尿酸血症动物模型研究述评[J].湖南中医药大学学报，2017，37(12)：1431-1436.
[10] RUSSELL S T， TISDALE M J. Mechanism of attenuation of skeletal muscle atrophy by zinc-alpha2-glycoprotein[J]. Endocrinology，2010，151(10)： 4696-4704.
[11] BURGI W， SCHMID K. Preparation and properties of Zn-alph a 2-glycoprotein of normal human plasma[J]. J Biol Chem，1961，236：1066-1074.
[12] SANCHEZ L M， CHIRINO A J， BJORKMAN P. Crystal structure of human ZAG， a fat-dep letting factor related to MHC molecu les[J]. Science， 1999， 283(5409)：1914-1919.
[13] BING C， BAOY， JENKINS J， et al. Zinc-alpha2-glycoprotein， a lipid mobil-izing factor， is expressed in adipocytes and isup-regulated in mice with can-cer cachexia. Proc Natl Acad[J]. SciU SA， 2004， 101(8)：2500-2505.
[14] DUNSTAN D W， ZIMMET P Z， WELBORN T A， et al. The rising prevalence of diabetes and impaired glucose tolerance： The Australian Diabetes， Obesity and Lifestyle Study[J]. Diabetes Care， 2002，25(5)：829-834.
[15] MRACEKT， DING Q， TZANAVARI T， et al. Theadipokine zinc-α2-glycoprotein is downregulated with fat mass expansion in obesity[J]. Clin Endocrinol(Oxf)， 2010，72(3)：334-341.
[16] SELVA D M， LECUBE A， HERNANDEZ C， et al. Lower zinc-{alpha}2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance[J]. J Clin Endocrinol Meta， 2009，94(11)：4499-4507.
[17] MRACEKT， GAO D， TZANAVARI T， et al. Downregulation of zinc-α2-glycoprotein in adipose tissue and liver of obese ob/ob mice and by tumour necrosis factor-αin adipocytes[J]. J Endocrinol，2010，204(2)：165-172.
[18] GOHDA T， MAKITA Y， SHIKE T， et al. Identification of epistatic interaction Involved in obesity using the KK/Ta mouse as a Type2 diabetesmodel： is Zn-alpha2 glycoprotein-1acandidate gene for obesity？[J]. Diabetes， 2003，52(8)：2175-2181., 百拇医药(刘李玟韬 杨洁 陈秉朴)